• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种评估估算心理健康障碍患病率研究的偏倚风险的工具(心理健康障碍患病率偏倚风险评估工具)

A tool to assess risk of bias in studies estimating the prevalence of mental health disorders (RoB-PrevMH).

作者信息

Tonia Thomy, Buitrago-Garcia Diana, Peter Natalie, Mesa-Vieira Cristina, Li Tianjing, Furukawa Toshi A, Cipriani Andrea, Leucht Stefan, Low Nicola, Salanti Georgia

出版信息

medRxiv. 2023 Feb 2:2023.02.01.23285335. doi: 10.1101/2023.02.01.23285335.

DOI:10.1101/2023.02.01.23285335
PMID:36778304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9915820/
Abstract

OBJECTIVE

Biases affect how certain we are about the available evidence, however no standard tool for assessing the risk of bias (RoB) in prevalence studies exists. For the purposes of a living systematic review on prevalence of mental health disorders during the COVID-19 pandemic, we developed a RoB tool to evaluate prevalence studies in mental health (RoB-PrevMH) and tested interrater reliability.

METHODS

We reviewed existing RoB tools for prevalence studies until September 2020, to develop a tool for prevalence studies in mental health. We tested the reliability of assessments by different users of RoB-PrevMH in 83 studies stemming from two systematic reviews of prevalence studies in mental health. We assessed the interrater agreement by calculating the proportion of agreement and Kappa statistic for each item.

RESULTS

RoB-PrevMH consists of three items that address selection bias and information bias. Introductory and signaling questions guide the application of the tool to the review question. The interrater agreement for the three items was 83%, 90% and 93%. The weighted kappa was 0.63 (95% CI 0.54 to 0.73), 0.71 (95% CI 0.67 to 0.85) and 0.32 (95% CI -0.04 to -0.63), respectively.

CONCLUSIONS

We developed a brief, user friendly, and adaptable tool for assessing RoB in studies on prevalence of mental health disorders. Initial results for interrater agreement were fair to substantial. The tool's validity, reliability, and applicability should be assessed in future projects.

摘要

目的

偏倚会影响我们对现有证据的确信程度,然而目前尚无用于评估患病率研究中偏倚风险(RoB)的标准工具。为了对2019冠状病毒病(COVID-19)大流行期间心理健康障碍的患病率进行实时系统评价,我们开发了一种RoB工具来评估心理健康方面的患病率研究(RoB-PrevMH),并测试了评分者间信度。

方法

我们检索了截至2020年9月的现有患病率研究RoB工具,以开发一种心理健康患病率研究工具。我们在两项心理健康患病率研究系统评价中的83项研究中,测试了不同使用者对RoB-PrevMH评估的可靠性。我们通过计算每项的一致性比例和Kappa统计量来评估评分者间的一致性。

结果

RoB-PrevMH由三个涉及选择偏倚和信息偏倚的项目组成。引导性问题和信号问题指导该工具应用于综述问题。这三个项目的评分者间一致性分别为83%、90%和93%。加权Kappa分别为0.63(95%CI 0.54至0.73)、0.71(95%CI 0.67至0.85)和0.32(95%CI -0.04至 -0.63)。

结论

我们开发了一种简短、用户友好且可调整的工具,用于评估心理健康障碍患病率研究中的RoB。评分者间一致性的初步结果为尚可至较高。该工具的有效性、可靠性和适用性应在未来项目中进行评估。

相似文献

1
A tool to assess risk of bias in studies estimating the prevalence of mental health disorders (RoB-PrevMH).一种评估估算心理健康障碍患病率研究的偏倚风险的工具(心理健康障碍患病率偏倚风险评估工具)
medRxiv. 2023 Feb 2:2023.02.01.23285335. doi: 10.1101/2023.02.01.23285335.
2
Tool to assess risk of bias in studies estimating the prevalence of mental health disorders (RoB-PrevMH).评估估计心理健康障碍患病率的研究偏倚风险的工具 (RoB-PrevMH)。
BMJ Ment Health. 2023 Oct;26(1). doi: 10.1136/bmjment-2023-300694.
3
Using a large language model (ChatGPT) to assess risk of bias in randomized controlled trials of medical interventions: protocol for a pilot study of interrater agreement with human reviewers.使用大语言模型(ChatGPT)评估医学干预随机对照试验中的偏倚风险:与人类评审员进行评分者间一致性的初步研究方案
BMC Med Res Methodol. 2025 Jul 31;25(1):182. doi: 10.1186/s12874-025-02631-0.
4
Individual participant data informed risk of bias assessments for randomized controlled trials in systematic reviews and meta-analyses.个体参与者数据为系统评价和荟萃分析中随机对照试验的偏倚风险评估提供了依据。
J Clin Epidemiol. 2025 Sep;185:111875. doi: 10.1016/j.jclinepi.2025.111875. Epub 2025 Jun 26.
5
A New Measure of Quantified Social Health Is Associated With Levels of Discomfort, Capability, and Mental and General Health Among Patients Seeking Musculoskeletal Specialty Care.一种新的量化社会健康指标与寻求肌肉骨骼专科护理的患者的不适程度、能力以及心理和总体健康水平相关。
Clin Orthop Relat Res. 2025 Apr 1;483(4):647-663. doi: 10.1097/CORR.0000000000003394. Epub 2025 Feb 5.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
The Ultrashort Mental Health Screening Tool Is a Valid and Reliable Measure With Added Value to Support Decision-making.超短心理健康筛查工具具有有效性和可靠性,并且具有附加价值,可以支持决策。
Clin Orthop Relat Res. 2024 Jan 1;482(1):59-70. doi: 10.1097/CORR.0000000000002718. Epub 2023 Jun 20.
8
Interventions for preventing falls in older people in care facilities.护理机构中预防老年人跌倒的干预措施。
Cochrane Database Syst Rev. 2025 Aug 20;8:CD016064. doi: 10.1002/14651858.CD016064.
9
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
10
Developing and testing of an assessment tool for appropriate psychotropic drug prescribing in people with intellectual disabilities.开发和测试一种用于智障人士合理开具精神药物处方的评估工具。
Ther Adv Drug Saf. 2025 Jul 8;16:20420986251342351. doi: 10.1177/20420986251342351. eCollection 2025.